Pharmacology of Sotalol Hydrochloride; Pharmacokinetics, Mechanism of Action, Uses, Effects

1 Views • 08/26/25

Side Effects

Subscribers

Sotalol is a non-selective beta-adrenergic receptor blocker with class III antiarrhythmic properties. It is widely used for the management of various cardiac arrhythmias due to its unique combination of beta-blocking and potassium channel-blocking effects. Below is a detailed breakdown of its pharmacology:

Mechanism of Action
Beta-Adrenergic Receptor Blockade (Class II)

Sotalol non-selectively blocks beta-1 and beta-2 adrenergic receptors, leading to:

Decreased heart rate (negative chronotropy).

Reduced myocardial contractility (negative inotropy).

Prolongation of atrioventricular (AV) nodal conduction time, which helps control heart rate during arrhythmias.

Potassium Channel Blockade (Class III)

Sotalol blocks delayed rectifier potassium channels (IKr), which prolongs the action potential duration and the effective refractory period in cardiac myocytes.

This effect reduces the risk of reentrant arrhythmias and stabilizes cardiac rhythms.

Pharmacokinetics
Administration:

Administered orally or intravenously.

Absorption:

Well-absorbed after oral administration, with a bioavailability of approximately 90–100%.

Distribution:

Does not bind significantly to plasma proteins, and its volume of distribution is relatively small.

Metabolism:

Sotalol is not significantly metabolized; most of the drug remains unchanged.

Excretion:

Primarily excreted unchanged via the kidneys. Renal function plays a critical role in its clearance.

Half-Life:

The elimination half-life is approximately 10–20 hours, depending on renal function.

Indications
Supraventricular Arrhythmias:

Used for conditions such as atrial fibrillation (AF) or atrial flutter.

Ventricular Arrhythmias:

Effective in treating life-threatening ventricular tachycardia or preventing ventricular fibrillation.

Maintenance of Sinus Rhythm:

Helps in maintaining sinus rhythm after cardioversion in patients with AF.

Adverse Effects
Cardiac Effects:

Prolongation of the QT interval, which increases the risk of torsades de pointes (a life-threatening ventricular arrhythmia).

Bradycardia and AV block.

Negative inotropic effects can precipitate heart failure in susceptible patients.

Non-Cardiac Effects:

Fatigue and dizziness.

Shortness of breath (due to beta-2 blockade causing bronchospasm, particularly in asthmatic patients).

Gastrointestinal discomfort (e.g., nausea, vomiting).

Electrolyte Abnormalities:

Hypokalemia and hypomagnesemia can exacerbate QT prolongation and arrhythmic risk.

#Sotalol

Up next

Pharmacology of Sotalol Hydrochloride; Pharmacokinetics, Mechanism of Action, Uses, Effects

Up next

Please note that if you are under 18, you won't be able to access this site.

Up next

Pharmacology of Sotalol Hydrochloride; Pharmacokinetics, Mechanism of Action, Uses, Effects

Up next

Language